<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2017</study_start_year><condition>Colorectal Neoplasms</condition><condition>Colorectal Cancer Metastatic</condition><disease>Colorectal Neoplasms</disease><disease>Colorectal Cancer Metastatic</disease><study_type>Observational patient registry</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2228700</full_dataset_link><study_start_month>1</study_start_month><keyword>Cetuximab</keyword><keyword>CTCs</keyword><keyword>Metastatic colorectal cancer</keyword><keyword>Ct DNA</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC</name><description>Evaluation of individual peripheral blood circulating tumor cells combined with tumor marker detection of efficacy of chemotherapy in patients with advanced colorectal cancer: A observational clinical trial</description><dates><creation>2017-01-15</creation></dates><accession>2228700</accession><cross_references><ClinicalTrials___gov>NCT02948985</ClinicalTrials___gov></cross_references></HashMap>